Reported Oct 7, 2026 · Ongoing · Updated Oct 13, 2026
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,…
Ajanta Pharma USA Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Ajanta Pharma USA Inc · 400 Crossing Blvd Ste 102 · Bridgewater, NJ · 08807-2863
Is this the product you have?
- Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only
- Marketed byAjanta Pharma USA Inc., Bridgewater, NJ 08807
- NDC27241-126-02
- Lot codes and dates
- Lot
DJ25134Exp 11/30/2028
- Lot
Where it was sold
- Nationwide
Why it was recalled
Failed Dissolution Specifications: below specification
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Ajanta Pharma USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.